I found it truly inspiring to participate in the launch day of the Venture Builder programme and witness the incredible innovation and energy from all the new businesses. The enthusiasm and creativity on display at LIHE were remarkable, and I am excited to see the amazing developments that will emerge from this initiative.
Riccardo Secoli, Senior Consultant, BU Healthcare, Cambridge Consultants
11 September 2024
UK's first MedTech Venture Builder backs 12 new companies
The London Institute for Healthcare Engineering (LIHE) has launched its inaugural MedTech Venture Builder programme, funded by Research England.
In a UK first, 12 companies have been selected to undertake the ground-breaking, 12-month programme that will provide the structures that are critical to building a robust MedTech company. These include regulatory plans, clinical evidence roadmaps and stakeholder mapping, all within a fit-for-purpose, medical grade, Quality Management System (QMS). This executive support is delivered by King’s specialist in-house translation teams, all housed in LIHE.
The aspiring MedTech companies, who are developing innovative products ranging from pure Software as a Medical Device to active implants and advanced surgical robotics, have further been matched with experts-in-residence to provide extensive hands-on guidance and monthly strategic progress reviews. Importantly, all the companies will receive guidance from one of the UK’s foremost innovation consultancies, Cambridge Consultants, who are a strategic partner to the programme.
The MedTech Venture Builder is a collaborative effort delivered by a consortium made up of four partner institutions, with King’s College London as the lead and working in partnership with Queen Mary University of London, City University of London, and St George’s University of London, to create a Collaborative Centre of Excellence (CCoE) for Medical Device translation. The program is delivered by King’s College London at LIHE.
Cutting-edge MedTech research requires extensive translation support to achieve real clinical and commercial impact. With the support of Research England, King’s College London, and in collaboration with our consortium partners, our MedTech Venture Builder has become the destination for promising startups from across the UK to receive this critical support. We are proud to be leading this ground-breaking effort, and we are looking forward to expanding it further in the near future.
Professor Bashir M. Al-Hashimi, Vice President (Research and Innovation)
The MedTech Venture Builder is the UK’s first go-to programme for the translation of the most cutting-edge and challenging MedTech innovations, generously supported by Research England, and hosted in our landmark LIHE. The strength of our consortium and of our partnerships means we can support ventures from across MedTech, from Software as a Medical Device, to active implants, to surgical robotics. We are excited to be welcoming 12 ground-breaking ventures, selected based on our conviction of their future impact to patients.
Professor Sebastien Ourselin FREng FMedSci, Director of the London Institute for Healthcare Engineering, Head of School, School of Biomedical Engineering & Imaging Sciences
In this story
Vice President (Research & Innovation)
Professor of Healthcare Engineering